Gastric cancer classification in simple words

Reading File
Finding Sources
Searching the Web

gastric cancer classification Lauren WHO simple overview

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Loading Image
Searching Images

Borrmann classification gastric cancer gross types

Loading Image
Loading Image
Here is a clear, structured overview of gastric cancer classification from the ground up.

Gastric Cancer Classification — Simple Overview

Almost all gastric cancers (>90%) are adenocarcinomas (cancer of gland-forming cells). They are classified in several overlapping ways:

1. By Depth of Invasion (Stage)

The most clinically important split:
StageWhat it meansPrognosis
Early gastric cancer (EGC)Cancer stays in mucosa/submucosa — regardless of lymph node spreadExcellent — ~90% 5-year survival
Advanced gastric cancerCancer invades into the muscle layer and beyondPoor — <20% 5-year survival in the West

2. By Gross (Visible) Appearance — The Japanese & Borrmann Classifications

Early Gastric Cancer (Japanese Classification)

Japanese classification of early gastric cancer
TypeAppearance
Type IProtruding / polypoid bump
Type IIaSlightly raised
Type IIbFlat
Type IIcSlightly depressed
Type IIIUlcerated crater

Advanced Gastric Cancer (Borrmann Classification, 1926)

Borrmann classification of advanced gastric cancer
TypeWhat it looks likeKey point
IPolypoid — mushroom-like massBest prognosis
IIUlcerating — deep ulcer with sharp edgesClearly defined
IIIUlcerating + infiltrating — ragged edgesMost common
IVDiffusely infiltrating — "linitis plastica" (leather-bottle stomach)Worst prognosis
Types III and IV are usually incurable at diagnosis.

3. By Microscopic Appearance — Laurén Classification (1965)

The most clinically used histological system:
Intestinal vs diffuse gastric cancer — gross and microscopic
FeatureIntestinal TypeDiffuse Type
Cell arrangementForms glands (organized)Loose single cells, no glands
Look under microscopeWell-differentiatedPoorly differentiated; signet ring cells (mucin pushes nucleus to side)
How it growsPolypoid or ulcerated massSpreads through stomach wall silently
Who gets itOlder men, high-incidence areas (Asia, S. America)Both sexes, younger patients
Associated withH. pylori, intestinal metaplasia, atrophic gastritisCDH1 mutation; blood type A
Metastasis patternTends to go to liverTends to go to peritoneum
PrognosisBetterWorse
There is also a Mixed type (both components → intermediate-poor prognosis) and an Indeterminate type.

4. By WHO Microscopic Subtypes (2019)

The WHO gives more detail, but roughly maps back to Laurén:
WHO SubtypeFrequencyCorresponds to Laurén
Tubular adenocarcinomaMost common (45–64%)Intestinal
Papillary adenocarcinoma3–10%; higher liver mets riskIntestinal
Poorly cohesive (incl. signet ring cell)20–54%Diffuse
Mucinous adenocarcinoma2–8%Mixed
Mixed-pattern6–22%; poor prognosisMixed

5. By Location in the Stomach

LocationNotes
Cardia / proximalCommon in low-incidence regions (UK, N. America); linked to GERD
Distal (antrum/body)Common in high-incidence regions (Asia, Eastern Europe); linked to H. pylori
In high-incidence areas, 80% are distal. In the West, 50–60% are proximal/cardia.

6. By Molecular Subtype — TCGA Classification (2014)

The Cancer Genome Atlas divided gastric cancer into 4 molecular subtypes with different drivers and treatment implications:
SubtypeKey featureHistology link
EBV-positiveEpstein-Barr virus in tumor cells; good response to immunotherapyGood prognosis
MSI (Microsatellite unstable)DNA mismatch repair defects; responds well to checkpoint inhibitorsIntestinal-like
CIN (Chromosomal instability)TP53 mutations; most commonIntestinal type
GS (Genomically stable)CDH1 / RHOA mutationsDiffuse type; worst prognosis

Quick Summary Table

SystemWhat it tells you
Early vs AdvancedDepth of wall invasion → prognosis & curability
Japanese classificationShape of early lesions → guides endoscopic treatment
BorrmannShape of advanced lesions → gross surgical/endoscopic description
LaurénIntestinal vs diffuse → biology, epidemiology, spread pattern
WHODetailed microscopic subtypes
TCGA molecularGenetic drivers → targeted therapies, immunotherapy eligibility

Sources: Bailey & Love's Short Practice of Surgery (28th ed.), Sabiston Textbook of Surgery, Yamada's Textbook of Gastroenterology (7th ed.)
This is a shared conversation. Sign in to Orris to start your own chat.